Thienel, manuela, et al.(2022)."impairment of quality of life in patients with implanted subcutaneous cardioverter defibrillator (s-icd) compared to implanted transvenous cardioverter defibrillator therapy".Patient preference and adherence 2022:16 3027-3033.Https://doi.Org/10.2147/ppa.S378741.It was reported in a journal article review of 52 patients implanted with a subcutaneous implantable cardioverter defibrillator (s-icd) and 52 patients implanted with a transvenous implantable cardioverter defibrillator (tv-icd), 27.7% of s-icd patients expected their quality of life to improve by either deactivation or explantation of their device.Both s-icd and tv-icd groups reported inappropriate shock (ias) therapy, with a rate of 4.8 ias per patient year for the s-icd group.Patients reported pain, mental stress, and fear as a result of their shocks.Patient also reported discomfort and pain from the s-icd pocket itself.Of note, the study looked at patient implanted with 2nd- or 3rd-generation s-icd (boston scientific serial numbers a209 and a219).No additional information besides the journal article is available.
|